| Serial Number | 97208254 |
| Word Mark | SILICON THERAPEUTICS |
| Filing Date | Friday, January 7, 2022 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, September 12, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 18, 2023 |
| Description of Mark | The mark consists of lines forming a hexagonal border around a circle in blue followed by the word "SILICON" in black and the word "THERAPEUTICS" in blue under the word "SILICON". |
| Indication of Colors claimed | The color(s) blue and black is/are claimed as a feature of the mark. |
| Goods and Services | Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions |
| Disclaimer with Predetermined Text | "THERAPEUTICS" |
| Goods and Services | Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; medical research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; biomedical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Pharmaceutical research and development; Product research and development; Scientific research and development; Pharmaceutical product development for new small molecules aimed at degrading disease-causing cellular proteins for treatment in the field of oncology |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 14, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 14, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PHARMAVANT 8, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10036 |
| Party Name | PHARMAVANT 8, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10036 |
| Event Date | Event Description |
| Tuesday, September 12, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 18, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 18, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 28, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, June 12, 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, May 31, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, April 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 27, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 27, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, October 27, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, October 14, 2022 | ASSIGNED TO EXAMINER |
| Monday, February 14, 2022 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Sunday, February 13, 2022 | ASSIGNED TO LIE |
| Wednesday, February 9, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Saturday, January 15, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, January 14, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 11, 2022 | NEW APPLICATION ENTERED |